In a transformative move for Canadian healthcare, CHU Sainte-Justine and the Hospital for Sick Children (SickKids) are combining forces to revolutionize the future of pediatric medicine with the support of a $50 million investment from the Azrieli Foundation.
This project aims to create a discovery and research pipeline between Canada’s top pediatric hospitals that together treat most acute pediatric cases (61 per cent) in this country. This will result in better outcomes, improved quality of life and tailored medical care for children nationwide.
“Precision Child Health is more than just a shift in the approach to children’s health care”, says Dr. Ronald Cohn, President and CEO of SickKids. “To shift to this new paradigm and redefine the care trajectory, it will take tremendous financial and strategic investment – and thanks to the vision and generosity of the Azrieli Foundation, we are on our way.”
Precision Child Health uses information about a child’s genes, biology, environment, and social determinants to predict, prevent, diagnose and treat disease in a more targeted and individualized way. The approach has dramatic implications for children’s health into adulthood.
Through pioneering research, cutting-edge technology, and a deep understanding of the unique needs of each young patient, the partnership transcends traditional boundaries. It promises a future where every child in Canada receives healthcare that is as unique as their DNA.
“This partnership is based on excellence, visionary leadership and courageous collaboration,” says Naomi Azrieli, O.C., D.Phil, Chair and CEO of the Azrieli Foundation. “By bringing together the brilliant minds, collective expertise and considerable resources of Sainte-Justine and SickKids, we are working to shape healthier tomorrows for children nationwide.”